BioMarin
$90.649876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$90.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.36 (-2.54%) As of 3:03 PM EST today
-$2.36 (-2.54%) Today
Why Robinhood?
You can buy or sell BioMarin and other stocks, options, ETFs, and crypto commission-free!
About BMRN
BioMarin Pharmaceutical Inc. Common Stock, also called BioMarin, is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Read More Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Employees
2,849
Headquarters
San Rafael, California
Founded
1997
Market Cap
16.11B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.22M
High Today
$93.71
Low Today
$89.70
Open Price
$93.22
Volume
1.23M
52 Week High
$96.20
52 Week Low
$62.88
Collections
BMRN News
ReutersFeb 20
BRIEF-Biomarin's Biologics License Application For Valoctocogene Roxaparvovec Accepted For Priority Review By FDA With Review Action Date Of August 21, 2020
Feb 20 (Reuters) - Biomarin Pharmaceutical Inc: * BIOMARIN’S BIOLOGICS LICENSE APPLICATION FOR VALOCTOCOGENE ROXAPARVOVEC ACCEPTED FOR PRIORITY REVIEW BY FDA WAnalyst Ratings
81%
of 26 ratings
Buy
81%
Hold
19%
Sell
0%
BMRN Earnings
-$0.32
-$0.11
$0.09
$0.30
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.07 per share
Actual
Available Feb 26, After Hours
People Also Bought
Bristol-Myers Squibb
7,779
$61.97
-3.13%Gilead Sciences
17,818
$69.63
-4.49%Sangamo Therapeutics
4,943
$6.83
-3.39%Sarepta Therapeutics
2,038
$114.13
-4.55%Editas Medicine
10,092
$22.58
-4.68%bluebird bio
2,101
$73.01
-4.25%Bristol-Myers Squibb Comp...
$3.52
-3.55%AbbVie
27,043
$88.75
-4.72%CRISPR
26,972
$50.14
-3.50%Salesforce
37,659
$181.05
-2.63%Alexion Pharmaceuticals
1,853
$96.12
-2.93%Amarin
16,685